Related Articles
INHIBITION OF PROLIFERATION, ACTIVATION AND FUNCTION OF HUMAN NATURAL-KILLER-CELLS IN-VITRO BY SECRETED PRODUCTS OF LOVO, A COLORECTAL-CANCER CELL-LINE
Dysregulation of telomerase activity and expression in lymphokine-activated killer cells from advanced cancer patients: Possible involvement in cancer-associated immunosuppression mechanism
A new strategy using autologous dendritic cells and lymphokine-activated killer cells for cancer immunotherapy: efficient maturation of DCs by co-culture with LAK cells in vitro
Local anergy rather than systemic anti-tumour immunity to explain tumour growth in an animal model of oral squamous cell carcinoma
Enhancement of lymphokine-activated killer cell induction using anti-CD25 and anti-CTLA-4 monoclonal antibodies